Daniel Reed
banner
daniel-reed.bsky.social
Daniel Reed
@daniel-reed.bsky.social
Postdoctoral Researcher at Lund University in the Experimental Oncology Laboratory.
Passionate about all things intravital imaging and uncovering the mechanisms of the tumour microenvironment
Reposted by Daniel Reed
New review paper written by Jess Chitty in the team just out in Trends in Cancer (@cp-trendscancer.bsky.social) (OpenAccess)
The extracellular matrix in cancer: from understanding to targeting
| → www.sciencedirect.com/science/arti... ← |
The extracellular matrix in cancer: from understanding to targeting
Significant advances in matrix biology research have enhanced our understanding of individual matrix components and extracellular matrix (ECM) signall…
www.sciencedirect.com
June 3, 2025 at 11:46 PM
Reposted by Daniel Reed
Congratulations to @mbsanz.bsky.social MCR Paper of the Year 2024 Recipients, Brooke Pereira & Shona Ritchie, (co-led by @tcox.bsky.social ), for their latest work looking at the role of Nidogen-2 in pancreatic cancer published in Science Advances!

www.science.org/doi/10.1126/...
Temporally resolved proteomics identifies nidogen-2 as a cotarget in pancreatic cancer that modulates fibrosis and therapy response
Temporal mass spectrometry proteomics, advanced microscopy, and in vivo modeling reveal nidogen-2 as a cotarget in PDAC.
www.science.org
March 26, 2025 at 10:20 PM
Excited to kick off my Bluesky posting by sharing this work by the lab looking at the role of neuropeptideY in #pancreaticcancer metastasis. An amazing piece of work and so thrilled to see it finally out!

@garvaninstitute.bsky.social

www.science.org/doi/10.1126/...
Targeting the NPY/NPY1R signaling axis in mutant p53–dependent pancreatic cancer impairs metastasis
Targeting NPY1R reduces mutant p53–dependent pancreatic cancer metastasis.
www.science.org
March 14, 2025 at 12:47 AM